Bringing the fundamentals into focus…
Back to ImmunityBio, Inc.
How ImmunityBio, Inc. stacks up
IBRX · against 171 other Healthcare companies of similar size
Profitability
10/ 100
Near the bottom of its peers.
Ranked #163 of 172 · scores higher than 4% of peers
Bars: peers in each 10-point band of the profitability score10 peers with a profitability score of 10–19, including IBRX · Click a bar to see the companies
Why profitability scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 99% of peers. Return on assets: -157.9% vs peer median 1.7%
- a thinner operating margin: weaker than 89% of peers. Operating margin: -151.9% vs peer median 7.1%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = IBRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IBRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 167 reported | Not reported | 10.0% | — | — | 33% |
| Operating marginHigher is better · 163 reported | -151.9% | 12.8% | 4% | 33% | |
| Return on assetsHigher is better · 164 reported | -157.9% | 4.4% | 0% | 33% | |
| Return on equityHigher is better · 159 reported | Not reported | 8.9% | — | — | Context only |
| Gross marginHigher is better · 181 reported | 99.3% | 52.2% | 97% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around IBRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 3 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 3 | 170.4B THB (≈$4.8B) | 98 | 70 | |
| 5 | 4.6B USD | 97 | 65 | |
| 161 | 5.1B USD | 12 | 35 | |
| 161 | 10.5B USD | 12 | 56 | |
| 163 | 14.5B USD | 10 | 30 | |
| 163 | 6.2B USD | 10 | 44 | |
| 163 | 8.8B USD | 10 | 31 | |
| 166 | 7.7B USD | 9 | 36 | |
| 167 | 5.4B USD | 8 | 24 | |
| 168 | 5.7B USD | 5 | 52 | |
| 168 | 4.8B USD | 5 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score